Omega Therapeutics (OMGA) Competitors

Chimerix (NASDAQ:CMRX) and Omega Therapeutics (NASDAQ:OMGA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings, community ranking, media sentiment and institutional ownership.

Which has more volatility & risk, CMRX or OMGA?

Chimerix has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Omega Therapeutics has a beta of 1.84, indicating that its share price is 84% more volatile than the S&P 500.

Which has better valuation & earnings, CMRX or OMGA?

Chimerix has higher earnings, but lower revenue than Omega Therapeutics. Chimerix is trading at a lower price-to-earnings ratio than Omega Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chimerix	$320K	241.69	-$82.10M	-$0.94	-0.91
Omega Therapeutics	$6.31M	7.24	-$97.43M	-$1.33	-0.62

Does the MarketBeat Community favor CMRX or OMGA?

Chimerix received 362 more outperform votes than Omega Therapeutics when rated by MarketBeat users. However, 73.68% of users gave Omega Therapeutics an outperform vote while only 63.62% of users gave Chimerix an outperform vote.

Company	Underperform	Outperform
Chimerix	Outperform Votes 390 63.62%	Underperform Votes 223 36.38%
Omega Therapeutics	Outperform Votes 28 73.68%	Underperform Votes 10 26.32%

Does the media refer more to CMRX or OMGA?

In the previous week, Omega Therapeutics had 1 more articles in the media than Chimerix. MarketBeat recorded 10 mentions for Omega Therapeutics and 9 mentions for Chimerix. Chimerix's average media sentiment score of 0.59 beat Omega Therapeutics' score of -0.12 indicating that Chimerix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chimerix	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Omega Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is CMRX or OMGA more profitable?

Chimerix has a net margin of 0.00% compared to Omega Therapeutics' net margin of -1,249.54%. Chimerix's return on equity of -50.78% beat Omega Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chimerix	N/A	-50.78%	-44.94%
Omega Therapeutics	-1,249.54%	-156.48%	-40.77%

Do insiders & institutionals believe in CMRX or OMGA?

45.4% of Chimerix shares are owned by institutional investors. Comparatively, 97.5% of Omega Therapeutics shares are owned by institutional investors. 13.1% of Chimerix shares are owned by insiders. Comparatively, 8.5% of Omega Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Do analysts rate CMRX or OMGA?

Chimerix presently has a consensus price target of $8.50, suggesting a potential upside of 888.49%. Omega Therapeutics has a consensus price target of $9.20, suggesting a potential upside of 1,010.57%. Given Omega Therapeutics' higher probable upside, analysts plainly believe Omega Therapeutics is more favorable than Chimerix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chimerix	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Omega Therapeutics	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Summary

Chimerix and Omega Therapeutics tied by winning 9 of the 18 factors compared between the two stocks.